Long MREO @3.865--oversoldStandard oversold trade - buy lots as long as it remains oversold and sell each lot as it becomes overbought AND profitable.
Low price stocks like this are ideal for this type of trade because they tend to move more on a % basis than higher priced stocks. I'll post mmore data later but the chart t
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.29 USD
−43.27 M USD
0.00 USD
139.69 M
About Mereo BioPharma Group plc
Sector
Industry
CEO
Denise Vera Scots-Knight
Website
Headquarters
London
Founded
2015
FIGI
BBG00KFWZC67
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.
MREO - Huge Cup and HandleMereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some
$MREO Next Target PTs 2.50-4.50 and higher^ Key Words: I'm kicking us off with my pick, which is Mereo Biopharma. Now the stock was actually popping today on an article in "The Times" that says AstraZeneca is putting in a bid for the company. As you can see there, the stock up 73% there. And AstraZeneca also getting a slight boost as well.
Insider buying, volume, trial resultsLong with a small position established. Financials are looking good to 2025 with enough cash to meet demands of trials. Leading up to the osteogenesis imperfecta results was large cluster insider buying along with sentiment from CEO at interviews leading up to results being extremely positive. Volum
MREO 1D candle MERO:
A very, very interesting stock that jumped on the scanner (as a potential short squeeze stock)
Its data:
ID: (You can see a lots of insider and institutional deals)
finviz.com
Significant events in the near future (positive / negative catalysts):
finance.yahoo.com
Analyst Price Target on MREO
i can see 3 i can see 3 different patterns to push her higher
1) this flag i just drew out looks great looking for a break of $4.15
2) fill up a cup and handle, look at PD's chart, makes a U shape
3) inverse head and shoulders
all of these make sense for it to go to abt $6
after that and a cool off next le
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.